FDA Inspection 1135196 — Pfizer, Inc.
The FDA completed an inspection of Pfizer, Inc. on January 8, 2021 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 8, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Groton, CT (United States)